Chugai Pharmaceutical Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	15,260,701	13,565,544	11,516,953	8,789,053	5,540,406	6,141,311
Market Cap Growth	40.03%	17.79%	31.04%	58.64%	-9.79%	-32.11%
Enterprise Value	14,281,005	12,683,097	10,671,635	8,170,288	4,995,111	5,744,662
Last Close Price	9273.00	8243.00	6763.31	5083.63	3150.63	3416.66
PE Ratio	35.16	31.26	29.74	27.00	14.80	20.27
Forward PE	31.53	29.02	29.26	26.55	18.61	22.33
PS Ratio	12.13	10.78	9.84	7.91	4.40	6.14
PB Ratio	7.53	6.70	6.06	5.41	3.89	5.17
P/TBV Ratio	7.74	6.88	6.11	5.47	3.96	5.27
P/FCF Ratio	49.23	43.76	29.00	26.01	30.53	28.74
P/OCF Ratio	39.51	35.12	25.73	21.44	22.70	21.96
PEG Ratio	2.75	3.16	4.20	23.02	4.08	2.37
EV/Sales Ratio	11.35	10.08	9.12	7.35	3.97	5.75
EV/EBITDA Ratio	22.94	20.57	18.60	17.35	8.85	12.69
EV/EBIT Ratio	24.20	21.49	19.69	18.60	9.37	13.62
EV/FCF Ratio	46.07	40.91	26.87	24.17	27.52	26.89
Debt / Equity Ratio	-	-	0.01	0.01	0.01	0.01
Debt / EBITDA Ratio	-	-	0.02	0.03	0.02	0.04
Debt / FCF Ratio	-	-	0.03	0.04	0.08	0.08
Asset Turnover	0.54	0.54	0.56	0.59	0.74	0.72
Inventory Turnover	1.41	1.41	1.32	1.46	1.90	1.72
Quick Ratio	3.46	3.46	4.59	3.68	2.40	2.53
Current Ratio	4.24	4.24	5.53	4.74	3.15	3.25
Return on Equity (ROE)	22.10%	22.10%	21.96%	21.34%	28.67%	27.95%
Return on Assets (ROA)	15.77%	15.77%	16.36%	14.44%	19.56%	19.01%
Return on Invested Capital (ROIC)	41.72%	43.67%	42.57%	35.09%	45.09%	45.33%
Return on Capital Employed (ROCE)	28.70%	28.70%	28.30%	26.70%	36.90%	34.80%
Earnings Yield	2.84%	3.20%	3.36%	3.70%	6.76%	4.93%
FCF Yield	2.03%	2.28%	3.45%	3.84%	3.28%	3.48%
Dividend Yield	1.43%	1.48%	1.45%	1.57%	2.48%	2.22%
Payout Ratio	68.99%	68.99%	34.40%	40.43%	36.91%	32.56%
Buyback Yield / Dilution	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%
Total Shareholder Return	1.46%	1.47%	1.44%	1.56%	2.47%	2.21%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.